Back
McEwen, Inc. 10K Form
Sell
47
MUX
McEwen, Inc.
Last Price:
$21.48
Seasonality Move:
8.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | MUX/McEwen, Inc. Quarterly |
| 2023-08-09 | 10Q | MUX/McEwen, Inc. Quarterly |
| 2023-05-08 | 10Q | MUX/McEwen, Inc. Quarterly |
| 2022-11-04 | 10Q | MUX/McEwen, Inc. Quarterly |
| 2022-08-10 | 10Q | MUX/McEwen, Inc. Quarterly |
| 2022-05-10 | 10Q | MUX/McEwen, Inc. Quarterly |
Receive MUX News And Ratings
See the #1 stock for the next 7 days that we like better than MUX
MUX Financial Statistics
Sales & Book Value
| Annual Sales: | $197.6M |
|---|---|
| Cash Flow: | $-6.5M |
| Price / Cash Flow: | 43.51 |
| Annual Sales: | $10.30 |
| Price / Book: | 2.35 |
Profitability
| EPS (TTM): | 0.50240 |
|---|---|
| Net Income (TTM): | $34.4M |
| Gross Margin: | $20.9M |
| Return on Equity: | 6.9% |
| Return on Assets: | 4.65% |
McEwen, Inc. Earnings Forecast
Key McEwen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 42 years for MUX is 10.57%.
-
The Selling, General & Administrative Expenses for MUX have been equal to 13.51% of Gross Profit Margin.
-
The Research & Development expenses have been 2.86% of Revenue.
-
The Interest Expense is 20.96% of Operating Income.
-
The Net Earning history of MUX is 17.43% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 15 years.
McEwen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | MUX |
| CUSIP: | 58039P |
| Website: | mcewenmining.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 1.69 |
| Quick Ratio: | 1.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 41.04 |
|---|---|
| Forward P/E Ratio: | 4.41 |
MUX Technical Analysis vs Fundamental Analysis
Sell
47
McEwen, Inc. (MUX)
is a Sell
Is McEwen, Inc. a Buy or a Sell?
-
McEwen, Inc. stock is rated a SellThe current McEwen, Inc. [MUX] share price is $21.48. The Score for MUX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.